I agree with you, Benji. But at least this is the first med ever that I know about that in a clinical phase II trial for Alzheimer resulted in such spectaculair results. People on Rember could work from 2006 to 2012. That's amazing. Alzheimer goes quite fast. So the Rember must do something good. However, it was not been tested on PD patients. But this is really hope giving for AD patients. And considering it works on the mitochondrial level, this could possibly also be very hope giving for PD patients. I will not be surprised if many PD patients will take LMTX once it gets on the shelves, even before clinical trials on PD patients confirm whether LMTX is beneficial for PD or not.
I found this on wikipedia (http://en.wikipedia.org/wiki/Rember
"A larger Phase 3 trial is planned for 2009 with an idea to see whether methylene blue can prevent the formation of the disease in the first place. TauRx are also looking into starting a trial of the drug on patients suffering from Parkinson's disease; as methylene blue also has effects on the synuclein fibres in the brain."
Maybe someone knows more about these trials for PD ? Maybe the research team here ?